This site is intended for UK healthcare professionals

 

Supported

Dr Paul Foley and Prof Terry McCormack share the key changes in the new ESC guidance on atrial fibrillation, hypertension and arterial disease.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

Dr Sarah Birkhoelzer and Dr Aaron Henry discuss hot topics and late-breaking abstracts from across the congress.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

This webinar has been sponsored by A Menarini Pharmaceuticals Ireland and A. Menarini Farmaceutica Internazionale SRL who have had no input into the topics discussed or selection of speakers.

Watch this informative video short, featuring Dr Paul Andrews as he describes some of the pitfalls of digoxin use within the elderly population and explores ways to minimise the risks and correctly identify when to take action to treat potentially life threatening scenarios.
Watch Terry McCormack and Rani Khatib discuss the updates to lipid management guidelines to reduce the risk of cardiovascular disease and implications for clinical practice. They will provide an overview of which patients should be treated, outline the current lipid-lowering targets and introduce the range of suitable treatments.
Watch this informative video short, featuring Chim Lang and Su-Lee Xiao as they briefly discuss the history of digoxin and explore its continued use today. Learn more about the role that digoxin has in modern management of heart failure in the elderly and things to keep in mind when treating high-risk patients.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.